Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model

Angiogenesis requires the deposition of type IV collagen by endothelial cells into the basement membrane of new blood vessels. Stabilization of type IV collagen triple helix depends on the hydroxylation of proline, which is catalyzed by the iron-containing enzyme prolyl hydroxylase. This enzyme, in...

Full description

Bibliographic Details
Main Authors: Sucheta Telang, Amy L. Clem, John W. Eaton, Jason Chesney
Format: Article
Language:English
Published: Elsevier 2007-01-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558607800145
_version_ 1819140675006889984
author Sucheta Telang
Amy L. Clem
John W. Eaton
Jason Chesney
author_facet Sucheta Telang
Amy L. Clem
John W. Eaton
Jason Chesney
author_sort Sucheta Telang
collection DOAJ
description Angiogenesis requires the deposition of type IV collagen by endothelial cells into the basement membrane of new blood vessels. Stabilization of type IV collagen triple helix depends on the hydroxylation of proline, which is catalyzed by the iron-containing enzyme prolyl hydroxylase. This enzyme, in turn, requires ascorbic acid to maintain the enzyme-bound iron in its reduced state. We hypothesized that dietary ascorbic acid might be required for tumor angiogenesis and, therefore, tumor growth. Here, we show that, not surprisingly, ascorbic acid is necessary for the synthesis of collagen type IV by human endothelial cells and for their effective migration and tube formation on a basement membrane matrix. Furthermore, ascorbic acid depletion in mice incapable of synthesizing ascorbic acid (Gulo-/-) dramatically restricts the in vivo growth of implanted Lewis lung carcinoma tumors. Histopathological analyses of these tumors reveal poorly formed blood vessels, extensive hemorrhagic foci, and decreased collagen and von Willebrand factor expression. Our data indicate that ascorbic acid plays an essential role in tumor angiogenesis and growth, and that restriction of ascorbic acid or pharmacological inhibition of prolyl hydroxylase may prove to be novel therapeutic approaches to the treatment of cancer.
first_indexed 2024-12-22T11:42:19Z
format Article
id doaj.art-ba6a96eb8a5d4957ad8db90d2a17fde9
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-12-22T11:42:19Z
publishDate 2007-01-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-ba6a96eb8a5d4957ad8db90d2a17fde92022-12-21T18:27:14ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022007-01-0191475610.1593/neo.06664Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse ModelSucheta TelangAmy L. ClemJohn W. EatonJason ChesneyAngiogenesis requires the deposition of type IV collagen by endothelial cells into the basement membrane of new blood vessels. Stabilization of type IV collagen triple helix depends on the hydroxylation of proline, which is catalyzed by the iron-containing enzyme prolyl hydroxylase. This enzyme, in turn, requires ascorbic acid to maintain the enzyme-bound iron in its reduced state. We hypothesized that dietary ascorbic acid might be required for tumor angiogenesis and, therefore, tumor growth. Here, we show that, not surprisingly, ascorbic acid is necessary for the synthesis of collagen type IV by human endothelial cells and for their effective migration and tube formation on a basement membrane matrix. Furthermore, ascorbic acid depletion in mice incapable of synthesizing ascorbic acid (Gulo-/-) dramatically restricts the in vivo growth of implanted Lewis lung carcinoma tumors. Histopathological analyses of these tumors reveal poorly formed blood vessels, extensive hemorrhagic foci, and decreased collagen and von Willebrand factor expression. Our data indicate that ascorbic acid plays an essential role in tumor angiogenesis and growth, and that restriction of ascorbic acid or pharmacological inhibition of prolyl hydroxylase may prove to be novel therapeutic approaches to the treatment of cancer.http://www.sciencedirect.com/science/article/pii/S1476558607800145Ascorbic acidtumorangiogenesiscollagenprolyl hydroxylase
spellingShingle Sucheta Telang
Amy L. Clem
John W. Eaton
Jason Chesney
Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model
Neoplasia: An International Journal for Oncology Research
Ascorbic acid
tumor
angiogenesis
collagen
prolyl hydroxylase
title Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model
title_full Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model
title_fullStr Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model
title_full_unstemmed Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model
title_short Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model
title_sort depletion of ascorbic acid restricts angiogenesis and retards tumor growth in a mouse model
topic Ascorbic acid
tumor
angiogenesis
collagen
prolyl hydroxylase
url http://www.sciencedirect.com/science/article/pii/S1476558607800145
work_keys_str_mv AT suchetatelang depletionofascorbicacidrestrictsangiogenesisandretardstumorgrowthinamousemodel
AT amylclem depletionofascorbicacidrestrictsangiogenesisandretardstumorgrowthinamousemodel
AT johnweaton depletionofascorbicacidrestrictsangiogenesisandretardstumorgrowthinamousemodel
AT jasonchesney depletionofascorbicacidrestrictsangiogenesisandretardstumorgrowthinamousemodel